26,866 Shares in Oscar Health, Inc. $OSCR Purchased by Kingswood Wealth Advisors LLC

Key Points

• Kingswood Wealth Advisors LLC purchased 26,866 shares of Oscar Health, Inc. for approximately $576,000 in the second quarter, adding to the growing interest from institutional investors.
• Analysts have downgraded Oscar Health's stock, with a consensus rating of "Strong Sell" and a target price of $12.64, indicating a declining outlook for the company.
• Insider Mario Schlosser sold 395,000 shares of the stock, significantly reducing their position by 44.08%, raising concerns about insider sentiment regarding the company's future performance.

Kingswood Wealth Advisors LLC acquired a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 26,866 shares of the company's stock, valued at approximately $576,000.

Several other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in Oscar Health by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after acquiring an additional 700,469 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in Oscar Health by 4.1% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after acquiring an additional 467,301 shares during the last quarter. Thrive Capital Management LLC increased its holdings in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. BIT Capital GmbH grew its holdings in Oscar Health by 1.1% during the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after buying an additional 47,592 shares in the last quarter. Finally, Glynn Capital Management LLC grew its holdings in Oscar Health by 14.0% during the 1st quarter. Glynn Capital Management LLC now owns 3,115,217 shares of the company's stock valued at $40,840,000 after buying an additional 381,980 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Robert W. Baird reaffirmed a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a report on Friday, July 25th. UBS Group reaffirmed a "sell" rating and set a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Baird R W lowered Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Wall Street Zen lowered Oscar Health from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. Finally, Barclays reduced their target price on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a report on Wednesday, July 23rd. Four analysts have rated the stock with a Hold rating and six have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Strong Sell" and a consensus price target of $12.64.

Insiders Place Their Bets

In related news, insider Mario Schlosser sold 395,000 shares of the business's stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the sale, the insider owned 501,148 shares in the company, valued at $9,236,157.64. The trade was a 44.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 24.39% of the stock is owned by insiders.

Oscar Health Stock Performance

Shares of OSCR opened at $20.69 on Friday. The stock has a 50-day moving average price of $17.67 and a 200-day moving average price of $15.81. The company has a market cap of $5.35 billion, a PE ratio of -25.54 and a beta of 1.89. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80. The company has a current ratio of 0.86, a quick ratio of 0.86 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.Oscar Health's quarterly revenue was up 29.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.20 EPS. As a group, equities analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.